These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9174606)

  • 1. The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9.
    Braud V; Jones EY; McMichael A
    Eur J Immunol; 1997 May; 27(5):1164-9. PubMed ID: 9174606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
    Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
    Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific recognition of HLA-E, but not classical, HLA class I molecules by soluble CD94/NKG2A and NK cells.
    Brooks AG; Borrego F; Posch PE; Patamawenu A; Scorzelli CJ; Ulbrecht M; Weiss EH; Coligan JE
    J Immunol; 1999 Jan; 162(1):305-13. PubMed ID: 9886400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production, crystallization, and preliminary X-ray analysis of the human MHC class Ib molecule HLA-E.
    O'Callaghan CA; Tormo J; Willcox BE; Blundell CD; Jakobsen BK; Stuart DI; McMichael AJ; Bell JI; Jones EY
    Protein Sci; 1998 May; 7(5):1264-6. PubMed ID: 9605335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative peptide binding motifs of Qa-2 class Ib molecules define rules for binding of self and nonself peptides.
    Tabaczewski P; Chiang E; Henson M; Stroynowski I
    J Immunol; 1997 Sep; 159(6):2771-81. PubMed ID: 9300698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptides derived from the whole sequence of BCR-ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytes.
    Buzyn A; Ostankovitch M; Zerbib A; Kemula M; Connan F; Varet B; Guillet JG; Choppin J
    Eur J Immunol; 1997 Aug; 27(8):2066-72. PubMed ID: 9295046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation.
    Ulbrecht M; Modrow S; Srivastava R; Peterson PA; Weiss EH
    J Immunol; 1998 May; 160(9):4375-85. PubMed ID: 9574542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.
    Hoare HL; Sullivan LC; Clements CS; Ely LK; Beddoe T; Henderson KN; Lin J; Reid HH; Brooks AG; Rossjohn J
    J Mol Biol; 2008 Apr; 377(5):1297-303. PubMed ID: 18339401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qa-1b binds conserved class I leader peptides derived from several mammalian species.
    Kurepa Z; Hasemann CA; Forman J
    J Exp Med; 1998 Sep; 188(5):973-8. PubMed ID: 9730898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: requirement of class I signal sequence-derived peptides for HLA-E recognition by a mouse cytotoxic T cell clone.
    Martinozzi S; Pacasova R; Boulouis HJ; Ulbrecht M; Weiss EH; Sigaux F; Pla M
    J Immunol; 1999 May; 162(10):5662-5. PubMed ID: 10229795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
    Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
    Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qa-1 interaction and T cell recognition of the Qa-1 determinant modifier peptide.
    Cotterill LA; Stauss HJ; Millrain MM; Pappin DJ; Rahman D; Canas B; Chandler P; Stackpoole A; Simpson E; Robinson PJ; Dyson PJ
    Eur J Immunol; 1997 Sep; 27(9):2123-32. PubMed ID: 9341749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of the affinity of HLA class I-binding peptides lacking primary anchor residues by manipulation of the secondary anchor residues.
    Rovero P; Viganò S; Pegoraro S; Revoltella R; Riganelli D; Fruci D; Greco G; Butler RH; Tanigaki N
    J Pept Sci; 1995; 1(4):266-73. PubMed ID: 9223004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2m.
    Pedersen LO; Stryhn A; Holter TL; Etzerodt M; Gerwien J; Nissen MH; Thøgersen HC; Buus S
    Eur J Immunol; 1995 Jun; 25(6):1609-16. PubMed ID: 7614989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A negatively charged anchor residue promotes high affinity binding to the MHC class II molecule I-Ak.
    Nelson CA; Viner NJ; Young SP; Petzold SJ; Unanue ER
    J Immunol; 1996 Jul; 157(2):755-62. PubMed ID: 8752926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pattern search method for putative anchor residues in T cell epitopes.
    Hobohm U; Meyerhans A
    Eur J Immunol; 1993 Jun; 23(6):1271-6. PubMed ID: 7684684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A peptide binding motif for I-Eg7, the MHC class II molecule that protects E alpha-transgenic nonobese diabetic mice from autoimmune diabetes.
    Gregori S; Trembleau S; Penna G; Gallazzi F; Hammer J; Papadopoulos GK; Adorini L
    J Immunol; 1999 Jun; 162(11):6630-40. PubMed ID: 10352280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide.
    Braud VM; Allan DS; Wilson D; McMichael AJ
    Curr Biol; 1998 Jan; 8(1):1-10. PubMed ID: 9427624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.